Immatics (IMTX) Operating Leases (2019 - 2025)
Immatics (IMTX) posted Operating Leases of $15.0 million for Q4 2025, down 5.02% sequentially from $15.8 million in Q3 2025, and up 5.06% YoY from $14.3 million in Q4 2024.
Immatics (IMTX) Operating Leases (2019 - 2025) Analysis & Trends
Immatics has reported Operating Leases for 7 years, with the latest figure at $15.0 million in Q4 2025.
- Quarterly Operating Leases rose 5.06% year-over-year to $15.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $15.0 million (up 5.06% YoY) and the FY2025 annual result came in at $14.5 million, up 0.68% from the prior year.
- Operating Leases retreated to $15.0 million in Q4 2025 per IMTX's latest filing, from $15.8 million in the prior quarter.
- Over five years, Operating Leases peaked at $16.1 million in Q1 2025 and troughed at $5.2 million in Q3 2021.
- A 5-year average of $12.7 million and a median of $14.1 million in 2022 frame the typical range for Operating Leases.
- The sharpest annual moves came in 2021 and 2022: Operating Leases decreased 9.22% in 2021, then soared 169.38% in 2022.
- Over 5 years, Operating Leases stood at $11.3 million in 2021, then advanced by 12.27% to $12.7 million in 2022, then increased by 8.82% to $13.8 million in 2023, then gained by 3.62% to $14.3 million in 2024, then increased by 5.06% to $15.0 million in 2025.
- According to Business Quant data, Operating Leases over the past three periods registered $15.0 million, $15.8 million, and $16.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Immatics | 1.27 Bn | 719.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 14.99 Mn |
| Sep 30, 2025 | 15.78 Mn |
| Jun 30, 2025 | 15.97 Mn |
| Mar 31, 2025 | 16.14 Mn |
| Dec 31, 2024 | 14.27 Mn |
| Sep 30, 2024 | 14.49 Mn |
| Jun 30, 2024 | 15.33 Mn |
| Mar 31, 2024 | 12.90 Mn |
| Dec 31, 2023 | 13.77 Mn |
| Sep 30, 2023 | 14.88 Mn |
| Jun 30, 2023 | 15.34 Mn |
| Mar 31, 2023 | 13.43 Mn |
| Dec 31, 2022 | 12.65 Mn |
| Sep 30, 2022 | 13.97 Mn |
| Jun 30, 2022 | 14.92 Mn |
| Mar 31, 2022 | 7.29 Mn |
| Dec 31, 2021 | 11.27 Mn |
| Sep 30, 2021 | 5.19 Mn |
| Jun 30, 2021 | 5.70 Mn |
| Mar 31, 2021 | 5.28 Mn |